{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:36:18Z","timestamp":1777307778588,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-024-01814-6","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T04:03:23Z","timestamp":1729569803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Severe Adverse Reaction to Measles Vaccine Due to Homozygous Mutation in the IFNAR2 Gene: A Case Report and Literature Review"],"prefix":"10.1007","volume":"45","author":[{"given":"Ghaith","family":"Adi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaki","family":"Obaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deema Hassan","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asrar Mohammed Al","family":"Shahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assalh Ali","family":"Nahass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajer Abu","family":"Saud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faten Ahmed","family":"Alkateb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"1814_CR1","doi-asserted-by":"crossref","unstructured":"Rota PA, Moss WJ, Takeda M, De Swart RL, Thompson KM, Goodson JL, Measles. Nature Reviews Disease Primers 2016 2:1 [Internet]. 2016 Jul 14 [cited 2024 Jul 7];2(1):1\u201316. https:\/\/www.nature.com\/articles\/nrdp201649","DOI":"10.1038\/nrdp.2016.49"},{"key":"1814_CR2","doi-asserted-by":"crossref","unstructured":"Lee C, Robinson JL. Systematic review of the effect of immunization mandates on uptake of routine childhood immunizations. Journal of Infection [Internet]. 2016 Jun 1 [cited 2024 Jul 7];72(6):659\u201366. http:\/\/www.journalofinfection.com\/article\/S0163445316300299\/fulltext","DOI":"10.1016\/j.jinf.2016.04.002"},{"key":"1814_CR3","doi-asserted-by":"crossref","unstructured":"Jain R, Aulakh R, Measles-Associated CNS, Complications A, Review. J Child Sci [Internet]. 2022 [cited 2024 Jul 7];12:172\u201381. Available from: https:\/\/doi.org\/.","DOI":"10.1055\/s-0042-1757914"},{"key":"1814_CR4","doi-asserted-by":"crossref","unstructured":"Moss WJ, Measles. The Lancet [Internet]. 2017 Dec 2 [cited 2024 Jul 24];390(10111):2490\u2013502. http:\/\/www.thelancet.com\/article\/S0140673617314630\/fulltext","DOI":"10.1016\/S0140-6736(17)31463-0"},{"key":"1814_CR5","doi-asserted-by":"crossref","unstructured":"Costales C, Sahoo MK, Huang CH, Guimaraes CV, Born D, Kushner L et al. Vaccine-Associated Measles Encephalitis in Immunocompromised Child, California, USA. Emerg Infect Dis [Internet]. 2022 Apr 1 [cited 2024 Jul 24];28(4):906. \/pmc\/articles\/PMC8962891\/.","DOI":"10.3201\/eid2804.212357"},{"key":"1814_CR6","doi-asserted-by":"publisher","unstructured":"Fisher DL, Defres S, Solomon T. Measles-induced encephalitis. QJM: An International Journal of Medicine [Internet]. 2015 Mar 1 [cited 2024 Jul 24];108(3):177\u201382. https:\/\/doi.org\/10.1093\/qjmed\/hcu113","DOI":"10.1093\/qjmed\/hcu113"},{"key":"1814_CR7","doi-asserted-by":"publisher","unstructured":"Mogensen TH. Unexplored Roles of Type I Interferon in Antiviral Immunity and Regulation of Inflammation Revealed by Studying Patients With Inborn Errors of Immunity. Clinical Infectious Diseases [Internet]. 2022 Jan 7 [cited 2024 Jul 14];74(1):140\u20133. https:\/\/doi.org\/10.1093\/cid\/ciaa1798","DOI":"10.1093\/cid\/ciaa1798"},{"key":"1814_CR8","doi-asserted-by":"crossref","unstructured":"Duncan CJA, Mohamad SMB, Young DF, Skelton AJ, Leahy TR, Munday DC et al. Human IFNAR2 deficiency: lessons for antiviral immunity. Sci Transl Med [Internet]. 2015 Sep 9 [cited 2024 Jul 14];7(307):307ra154. \/pmc\/articles\/PMC4926955\/.","DOI":"10.1126\/scitranslmed.aac4227"},{"key":"1814_CR9","doi-asserted-by":"crossref","unstructured":"Passarelli C, Civino A, Rossi MN, Cifaldi L, Lanari V, Moneta GM et al. IFNAR2 Deficiency Causing Dysregulation of NK Cell functions and presenting with Hemophagocytic Lymphohistiocytosis. Front Genet. 2020;11.","DOI":"10.3389\/fgene.2020.00937"},{"key":"1814_CR10","doi-asserted-by":"crossref","unstructured":"Duncan CJA, Skouboe MK, Howarth S, Hollensen AK, Chen R, B\u00f8rresen ML et al. Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic. J Exp Med [Internet]. 2022 Jun 6 [cited 2024 Jul 14];219(6). \/pmc\/articles\/PMC9026249\/.","DOI":"10.1084\/jem.20212427"},{"key":"1814_CR11","doi-asserted-by":"crossref","unstructured":"Jouanguy E, Zhang SY, Chapgier A, Sancho-Shimizu V, Puel A, Picard C et al. Human primary immunodeficiencies of type I interferons. Biochimie [Internet]. 2007 Jun [cited 2024 Jul 24];89(6\u20137):878\u201383. https:\/\/pubmed.ncbi.nlm.nih.gov\/17561326\/","DOI":"10.1016\/j.biochi.2007.04.016"},{"key":"1814_CR12","doi-asserted-by":"crossref","unstructured":"Ameratunga R, Longhurst H, Lehnert K, Steele R, Edwards ESJ, Woon ST. Are All Primary Immunodeficiency Disorders Inborn Errors of Immunity? Front Immunol [Internet]. 2021 Jul 21 [cited 2024 Aug 3];12. Available from: \/pmc\/articles\/PMC8335567\/.","DOI":"10.3389\/fimmu.2021.706796"},{"key":"1814_CR13","doi-asserted-by":"crossref","unstructured":"McNab F, Mayer-Barber K, Sher A, Wack A, O\u2019Garra A. Type I interferons in infectious disease. Nature Reviews Immunology. 2015 15:2 [Internet]. 2015 Jan 23 [cited 2024 Jul 14];15(2):87\u2013103. https:\/\/www.nature.com\/articles\/nri3787","DOI":"10.1038\/nri3787"},{"key":"1814_CR14","doi-asserted-by":"crossref","unstructured":"Adi G. Severe adverse reaction to Measles Vaccine due to homozygous mutation in IFNAR2 gene: a Case Report and Literature Review of IFNAR2 mutation in a. Ten-Month-Old Infant. 2024;1.","DOI":"10.1007\/s10875-024-01814-6"},{"key":"1814_CR15","doi-asserted-by":"crossref","unstructured":"McCusker C, Upton J, Warrington R. Primary immunodeficiency. Allergy Asthma Clin Immunol [Internet]. 2018 Sep 12 [cited 2024 Jul 14];14(Suppl 2):61. \/pmc\/articles\/PMC6157160\/.","DOI":"10.1186\/s13223-018-0290-5"},{"key":"1814_CR16","doi-asserted-by":"crossref","unstructured":"Mahlaoui N, Warnatz K, Jones A, Workman S, Cant A. Advances in the Care of Primary Immunodeficiencies (PIDs): from Birth to Adulthood. J Clin Immunol [Internet]. 2017 Jul 1 [cited 2024 Jul 14];37(5):452. \/pmc\/articles\/PMC5489581\/.","DOI":"10.1007\/s10875-017-0401-y"},{"key":"1814_CR17","doi-asserted-by":"crossref","unstructured":"Jing H, Su HC. New Immunodeficiency syndromes that help us understand the IFN-mediated antiviral immune response. Curr Opin Pediatr [Internet]. 2019 Dec 1 [cited 2024 Jul 15];31(6):815. \/pmc\/articles\/PMC6993897\/.","DOI":"10.1097\/MOP.0000000000000827"},{"key":"1814_CR18","doi-asserted-by":"publisher","unstructured":"Salem S, Langlais D, Lefebvre F, Bourque G, Bigley V, Haniffa M et al. Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8K108E mutation. Blood [Internet]. 2014 Sep 18 [cited 2024 Jul 15];124(12):1894\u2013904. https:\/\/doi.org\/10.1182\/blood-2014-04-570879","DOI":"10.1182\/blood-2014-04-570879"},{"key":"1814_CR19","doi-asserted-by":"publisher","unstructured":"Salem S, Salem D, Gros P. Role of IRF8 in immune cells functions, protection against infections, and susceptibility to inflammatory diseases. Hum Genet [Internet]. 2020 Jun 1 [cited 2024 Jul 15];139(6\u20137):707\u201321. https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s00439-020-02154-2","DOI":"10.1007\/s00439-020-02154-2"},{"key":"1814_CR20","doi-asserted-by":"crossref","unstructured":"Sundararaj S, Casarotto MG. Molecular interactions of IRF4 in B cell development and malignancies. Biophys Rev [Internet]. 2021 Dec 1 [cited 2024 Jul 15];13(6):1219\u201327. https:\/\/link.springer.com\/article\/10.1007\/s12551-021-00825-6","DOI":"10.1007\/s12551-021-00825-6"},{"key":"1814_CR21","doi-asserted-by":"publisher","unstructured":"Hernandez N, Bucciol G, Moens L, Le Pen J, Shahrooei M, Goudouris E et al. Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines. Journal of Experimental Medicine [Internet]. 2019 Sep 2 [cited 2024 Aug 28];216(9):2057\u201370. https:\/\/doi.org\/10.1084\/jem.20182295","DOI":"10.1084\/jem.20182295"},{"key":"1814_CR22","doi-asserted-by":"crossref","unstructured":"Zhang G, Deweerd NA, Stifter SA, Liu L, Zhou B, Wang W et al. A proline deletion in IFNAR1 impairs IFN-signaling and underlies increased resistance to tuberculosis in humans. Nature Communications 2017 9:1 [Internet]. 2018 Jan 8 [cited 2024 Aug 28];9(1):1\u20139. https:\/\/www.nature.com\/articles\/s41467-017-02611-z","DOI":"10.1038\/s41467-017-02611-z"},{"key":"1814_CR23","unstructured":"Bastard P, Hsiao KC, Zhang Q, Choin J, Best E, Chen J et al. A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes. J Exp Med [Internet]. 2022 Jun 6 [cited 2024 Sep 5];219(6). \/pmc\/articles\/PMC9026234\/."},{"key":"1814_CR24","doi-asserted-by":"publisher","unstructured":"Hoyos-Bachiloglu R, Chou J, Sodroski CN, Beano A, Bainter W, Angelova M et al. A digenic human immunodeficiency characterized by IFNAR1 and IFNGR2 mutations. J Clin Invest [Internet]. 2017 Dec 1 [cited 2024 Jul 24];127(12):4415\u201320. https:\/\/doi.org\/10.1172\/JCI93486","DOI":"10.1172\/JCI93486"},{"key":"1814_CR25","doi-asserted-by":"publisher","unstructured":"Gothe F, Hatton CF, Truong L, Klimova Z, Kanderova V, Fejtkova M et al. A Novel Case of Homozygous Interferon Alpha\/Beta Receptor Alpha Chain (IFNAR1) Deficiency With Hemophagocytic Lymphohistiocytosis. Clinical Infectious Diseases [Internet]. 2022 Jan 7 [cited 2024 Aug 28];74(1):136\u20139. https:\/\/doi.org\/10.1093\/cid\/ciaa1790","DOI":"10.1093\/cid\/ciaa1790"},{"key":"1814_CR26","doi-asserted-by":"crossref","unstructured":"Khanmohammadi S, Rezaei N, Khazaei M, Shirkani A. A Case of Autosomal Recessive Interferon Alpha\/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19. J Clin Immunol [Internet]. 2022 Jan 1 [cited 2024 Aug 28];42(1):19\u201324. https:\/\/link.springer.com\/article\/10.1007\/s10875-021-01166-5","DOI":"10.1007\/s10875-021-01166-5"},{"key":"1814_CR27","doi-asserted-by":"publisher","unstructured":"Hernandez N, Melki I, Jing H, Habib T, Huang SSY, Danielson J et al. Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency. Journal of Experimental Medicine [Internet]. 2018 Oct 1 [cited 2024 Sep 6];215(10):2567\u201385. https:\/\/doi.org\/10.1084\/jem.20180628","DOI":"10.1084\/jem.20180628"},{"key":"1814_CR28","doi-asserted-by":"crossref","unstructured":"Gothe F, Stremenova Spegarova J, Hatton CF, Griffin H, Sargent T, Cowley SA et al. Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency. Journal of Allergy and Clinical Immunology [Internet]. 2022 Oct 1 [cited 2024 Sep 6];150(4):955\u2013964.e16. http:\/\/www.jacionline.org\/article\/S0091674922001853\/fulltext","DOI":"10.1016\/j.jaci.2022.01.026"},{"key":"1814_CR29","doi-asserted-by":"crossref","unstructured":"Huber M, Suprunenko T, Ashhurst T, Marbach F, Raifer H, Wolff S et al. IRF9 Prevents CD8\u2009+\u2009T Cell Exhaustion in an Extrinsic Manner during Acute Lymphocytic Choriomeningitis Virus Infection. J Virol [Internet]. 2017 Nov 15 [cited 2024 Sep 6];91(22):1219\u201336. https:\/\/journals.asm.org\/doi\/10.1128\/jvi.01219-17","DOI":"10.1128\/JVI.01219-17"},{"key":"1814_CR30","doi-asserted-by":"publisher","first-page":"1035532","DOI":"10.3389\/fimmu.2022.1035532","volume":"13","author":"AT Hanrath","year":"2022","unstructured":"Hanrath AT, Hatton CF, Gothe F, Browne C, Vowles J, Leary P, et al. Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia. Front Immunol. 2022;13:1035532.","journal-title":"Front Immunol"},{"key":"1814_CR31","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Bielma MF, Falf\u00e1n-Valencia R, Abarca-Rojano E, P\u00e9rez-Rubio G. Participation of Single-Nucleotide Variants in IFNAR1 and IFNAR2 in the Immune Response against SARS-CoV-2 Infection: A Systematic Review. Pathogens 2023, Vol 12, Page 1320 [Internet]. 2023 Nov 6 [cited 2024 Jul 17];12(11):1320. https:\/\/www.mdpi.com\/2076-0817\/12\/11\/1320\/htm.","DOI":"10.3390\/pathogens12111320"},{"key":"1814_CR32","doi-asserted-by":"crossref","unstructured":"Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol [Internet]. 2014 Jan [cited 2024 Sep 6];14(1):36. \/pmc\/articles\/PMC4084561\/.","DOI":"10.1038\/nri3581"},{"key":"1814_CR33","doi-asserted-by":"publisher","unstructured":"van der Made CI, Netea MG, van der Veerdonk FL, Hoischen A. Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19. Genome Medicine. 2022 14:1 [Internet]. 2022 Aug 19 [cited 2024 Jul 17];14(1):1\u201322. https:\/\/genomemedicine.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s13073-022-01100-3","DOI":"10.1186\/s13073-022-01100-3"},{"key":"1814_CR34","doi-asserted-by":"crossref","unstructured":"Sugrue JA, Bourke NM, O\u2019Farrelly C. Type I Interferon and the Spectrum of susceptibility to viral infection and Autoimmune Disease: A Shared genomic signature. Front Immunol [Internet]. 2021 Nov 30 [cited 2024 Jul 17];12:757249. Available from: www.frontiersin.org.","DOI":"10.3389\/fimmu.2021.757249"},{"key":"1814_CR35","doi-asserted-by":"crossref","unstructured":"Lurie RH, Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nature Reviews Immunology 2005 5:5 [Internet]. 2005 May [cited 2024 Jul 17];5(5):375\u201386. https:\/\/www.nature.com\/articles\/nri1604","DOI":"10.1038\/nri1604"},{"key":"1814_CR36","doi-asserted-by":"crossref","unstructured":"Lee AJ, Ashkar AA. The dual nature of type I and type II interferons. Front Immunol [Internet]. 2018 Sep 11 [cited 2024 Jul 17];9(SEP):403701. Available from: www.frontiersin.org.","DOI":"10.3389\/fimmu.2018.02061"},{"key":"1814_CR37","doi-asserted-by":"publisher","unstructured":"Stanifer ML, Guo C, Doldan P, Boulant S. Importance of type I and III interferons at respiratory and intestinal barrier surfaces. Front Immunol [Internet]. 2020;11:608645. Available from: https:\/\/doi.org\/10.3389\/fimmu.2020.608645","DOI":"10.3389\/fimmu.2020.608645"},{"key":"1814_CR38","doi-asserted-by":"crossref","unstructured":"Mogensen TH, IRF, Transcription Factors STAT. - From Basic Biology to Roles in Infection, Protective Immunity, and Primary Immunodeficiencies. Front Immunol [Internet]. 2018 [cited 2024 Jul 17];9(JAN):3047. \/pmc\/articles\/PMC6331453\/.","DOI":"10.3389\/fimmu.2018.03047"},{"key":"1814_CR39","doi-asserted-by":"crossref","unstructured":"Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I. Direct effects of type I interferons on cells of the immune system. Clinical Cancer Research [Internet]. 2011 May 1 [cited 2024 Jul 17];17(9):2619\u201327. \/clincancerres\/article\/17\/9\/2619\/12936\/Direct-Effects-of-Type-I-Interferons-on-Cells-of.","DOI":"10.1158\/1078-0432.CCR-10-1114"},{"key":"1814_CR40","doi-asserted-by":"crossref","unstructured":"Liang Y, Hannan R, Fu YX. Type I IFN activating type I dendritic cells for antitumor immunity. Clinical Cancer Research [Internet]. 2021 Jul 15 [cited 2024 Jul 17];27(14):3818\u201324. \/clincancerres\/article\/27\/14\/3818\/671521\/Type-I-IFN-Activating-Type-I-Dendritic-Cells-for.","DOI":"10.1158\/1078-0432.CCR-20-2564"},{"key":"1814_CR41","doi-asserted-by":"publisher","unstructured":"Zanin N, Viaris de Lesegno C, Lamaze C, Blouin CM. Interferon receptor trafficking and signaling: Journey to the Cross Roads. Front Immunol [Internet]. 2021;11:615603. Available from: https:\/\/doi.org\/10.3389\/fimmu.2020.615603","DOI":"10.3389\/fimmu.2020.615603"},{"key":"1814_CR42","doi-asserted-by":"crossref","unstructured":"Smieszek SP, Polymeropoulos VM, Xiao C, Polymeropoulos CM, Polymeropoulos MH. Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility. J Glob Antimicrob Resist [Internet]. 2021 Sep 1 [cited 2024 Jul 17];26:239. \/pmc\/articles\/PMC8279933\/.","DOI":"10.1016\/j.jgar.2021.06.005"},{"key":"1814_CR43","doi-asserted-by":"crossref","unstructured":"Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D et al. Genetic mechanisms of critical illness in COVID-19. Nature 2020 591:7848 [Internet]. 2020 Dec 11 [cited 2024 Jul 24];591(7848):92\u20138. https:\/\/www.nature.com\/articles\/s41586-020-03065-y","DOI":"10.1038\/s41586-020-03065-y"},{"key":"1814_CR44","doi-asserted-by":"crossref","unstructured":"Bastard P, Michailidis E, Hoffmann HH, Chbihi M, Le Voyer T, Rosain J et al. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine. J Exp Med [Internet]. 2021 Apr 4 [cited 2024 Aug 28];218(4). \/pmc\/articles\/PMC7871457\/.","DOI":"10.1084\/jem.20202486"},{"key":"1814_CR45","doi-asserted-by":"crossref","unstructured":"Frodsham AJ, Zhang L, Dumpis U, Taib NAM, Best S, Durham A et al. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc Natl Acad Sci U S A [Internet]. 2006 Jun 13 [cited 2024 Jul 17];103(24):9148\u201353. https:\/\/pubmed.ncbi.nlm.nih.gov\/16757563\/","DOI":"10.1073\/pnas.0602800103"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01814-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-024-01814-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01814-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:45:29Z","timestamp":1777304729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-024-01814-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1814"],"URL":"https:\/\/doi.org\/10.1007\/s10875-024-01814-6","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving humans were approved by King Fahad Medical City (KFMC) IRB Committee (23\u2013565). The studies were conducted in accordance with the local legislation and institutional requirements. The human samples used in this study were acquired from a by\u2013 product of routine care or industry. Written informed consent was obtained from the minor(s)\u2019 legal guardian\/next of kin for the publication of any potentially identifiable images or data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"30"}}